Premier Alternatives

Protogenix

Ithaca, NY · Founded 2021 · Privately Held (backing)

Developer of a protein manufacturing platform designed to replace mammalian cell systems used for producing complex proteins. Protogenix is based in Ithaca, NY and was founded in 2021. Its last reported valuation was $28 million in Dec 2024. It has raised $6.8 million across 1 recorded round; the latest was a $250,000 seed round in Dec 2025.

Last reported valuation
$28.0M
Oct 2026
Priced at
—
Total raised
$6.8M
Last round
Seed Round
Dec 2025

Protogenix key facts

as of Oct 2026
  • Developer of a protein manufacturing platform designed to replace mammalian cell systems used for producing complex proteins.
  • Protogenix is valued at approximately $28.0M as of Oct 2026 (last reported valuation).
  • It has raised $6.8M across 1 recorded rounds; the latest was Seed Round ($250K) in Dec 2025.
  • Notable investors include SOSV, IndieBio, New York Ventures, Skull Diamond and Heart Capital, Center for Life Science Ventures — 8 tracked in total.
  • Protogenix has filed 1 Form D with the SEC, most recently Feb 2026 ($250K sold to 1 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$28.0M

Protogenix's last reported valuation, Dec 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Protogenix with a free account
  • ·Watch Protogenix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Protogenix funding rounds

1 rounds
Dec 2025Seed Round$250KSEC filing▮
Full funding history →

Protogenix valuation

Protogenix's last reported valuation was $28 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Protogenix raised?

Protogenix has raised $6.8 million in total; 1 of its rounds is on record. The largest on record was a $250,000 seed round in Dec 2025.

Protogenix has filed 1 Form D with the SEC, most recently in Feb 2026 ($250,000 sold to 1 investor).

Protogenix investors

8 investors are on record for Protogenix, including SOSV, IndieBio, New York Ventures and Skull Diamond and Heart Capital. The seed round in Dec 2025 drew 1 investor.

About Protogenix

Developer of a protein manufacturing platform designed to replace mammalian cell systems used for producing complex proteins. The company offers decentralized production technology and plug-and-play processing methods that support yield protein generation for food and pharmaceutical applications, enabling producers to manufacture protein ingredients through alternative biological production processes.

Sector
Materials and Resources
HQ
Ithaca, NY, United States
Founded
2021
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.